Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cardiff LexingtonCDIX +0.79%27 Current Ratio is 0.98 as of Mar. 2026, which is 416% above its 10-year median of 0.19. GuruFocus rates CDIX with a GF Score™ of 27/100 and a GF Value™ of $0.08 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 681 Healthcare Providers & Services companies, Cardiff Lexington ranks worse than 74.01% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Cardiff Lexington's current ratio for the quarter that ended in Mar. 2026 was 0.98.
Cardiff Lexington has a current ratio of 0.98. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Cardiff Lexington has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Cardiff Lexington's Current Ratio or its related term are showing as below:
CDIX'
s Current Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.19 Max: 1.3
Current: 0.98
During the past 13 years, Cardiff Lexington's highest Current Ratio was 1.30. The lowest was 0.01. And the median was 0.19.
CDIX's Current Ratio is ranked worse than 74.01% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs CDIX: 0.98
Cardiff Lexington (OTCPK:CDIX) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Cardiff Lexington Current Ratio Related Terms
Cardiff Lexington Current Ratio Historical Data
* Premium members only.
The historical data trend for Cardiff Lexington's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Cardiff Lexington's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardiff Lexington Current Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cardiff Lexington's Current Ratio distribution charts can be found below:
* The bar in red indicates where Cardiff Lexington's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardiff Lexington (CDIX) has a Current Ratio of 0.98 as of Mar. 2026. This is 416% above median its historical median of 0.19. Over the past decade, Cardiff Lexington's Current Ratio has ranged from 0.01 to 1.30. According to the industry distribution chart, Cardiff Lexington ranks #504 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 74%.
Is Cardiff Lexington's Current Ratio too high?
Cardiff Lexington's current Current Ratio of 0.98 is 416% above median its 10-year median of 0.19. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 1.30. The Healthcare Providers & Services industry median Current Ratio is 1.47. Cardiff Lexington's value of 0.98 is 33.3% below this industry median. Based on the distribution chart, Cardiff Lexington ranks #504 out of 681 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Cardiff Lexington has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardiff Lexington's Current Ratio compare to AMS and SYRA?
According to the Healthcare Providers & Services industry distribution chart, Cardiff Lexington ranks #504 out of 681 companies for Current Ratio. This places Cardiff Lexington in the lower half of its industry. The industry median Current Ratio is 1.47. Cardiff Lexington's value of 0.98 is 33.3% below this benchmark. Historically, Cardiff Lexington's own Current Ratio has ranged from 0.01 to 1.30 over the past decade. While the company's 10-year median is 0.19 vs. the industry median of 1.47, Cardiff Lexington has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Healthcare Providers & Services company?
The median Current Ratio among Healthcare Providers & Services companies is 1.47, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cardiff Lexington's current Current Ratio of 0.98 is 33.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Current Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cardiff Lexington's current Current Ratio is 0.98, which is 416% above median its own 10-year median of 0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardiff Lexington stock overvalued right now?
Based on GuruFocus' analysis, Cardiff Lexington (CDIX) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.08, compared to a current price of $0.51 — trading 537.5% above its estimated fair value. The current Current Ratio is 0.98, which is 416% above median its 10-year median of 0.19 and 33.3% below the Healthcare Providers & Services industry median of 1.47. Cardiff Lexington's overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Cardiff Lexington (CDIX), the current Current Ratio is 0.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cardiff Lexington (CDIX) Overvalued in 2026?
Based on GuruFocus' analysis, Cardiff Lexington stock appears to be overvalued.
The current stock price of $0.51 is trading 537.5% above its estimated GF Value™ of $0.08.
GuruFocus considers Cardiff Lexington to be Significantly Overvalued.
Key valuation signals for CDIX:
Current Ratio: 0.98 (416% above median its 10-year median of 0.19)
GF Value™: $0.08 vs. price of $0.51 (537.5% above fair value)
Industry Position: 33.3% below the Healthcare Providers & Services median (#504 of 681)
No single metric tells the full story. See the CDIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cardiff Lexington Corp is an acquisition holding company, conducting its operations through its operating subsidiaries. The company has two reportable operating segments; Healthcare (Nova), and Real Estate (Edge View). The Healthcare segment generates all of the company's revenue and provides a full range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. The Real estate segment consists of Edge View, a real estate company that owns various acres zoned medium-density residential.
27GF Score
Get the complete analysis for CDIX
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CDIX has been successfully added to your 
